Logo image of TALK

TALKSPACE INC (TALK) Stock Fundamental Analysis

USA - NASDAQ:TALK - US87427V1035 - Common Stock

2.68 USD
+0.05 (+1.9%)
Last: 10/23/2025, 4:55:31 PM
2.69 USD
+0.01 (+0.37%)
After Hours: 10/23/2025, 4:55:31 PM
Fundamental Rating

5

TALK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While TALK has a great health rating, there are worries on its profitability. TALK shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year TALK was profitable.
TALK had a positive operating cash flow in the past year.
TALK had negative earnings in 4 of the past 5 years.
TALK had negative operating cash flow in 4 of the past 5 years.
TALK Yearly Net Income VS EBIT VS OCF VS FCFTALK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of TALK (2.16%) is comparable to the rest of the industry.
TALK's Return On Equity of 2.54% is in line compared to the rest of the industry. TALK outperforms 56.44% of its industry peers.
Industry RankSector Rank
ROA 2.16%
ROE 2.54%
ROIC N/A
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
TALK Yearly ROA, ROE, ROICTALK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

With a decent Profit Margin value of 1.41%, TALK is doing good in the industry, outperforming 60.40% of the companies in the same industry.
The Gross Margin of TALK (44.34%) is better than 72.28% of its industry peers.
TALK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1.41%
GM 44.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
TALK Yearly Profit, Operating, Gross MarginsTALK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

TALK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TALK has more shares outstanding
Compared to 5 years ago, TALK has more shares outstanding
TALK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TALK Yearly Shares OutstandingTALK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
TALK Yearly Total Debt VS Total AssetsTALK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 12.87 indicates that TALK is not in any danger for bankruptcy at the moment.
The Altman-Z score of TALK (12.87) is better than 95.05% of its industry peers.
TALK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.87
ROIC/WACCN/A
WACC8.61%
TALK Yearly LT Debt VS Equity VS FCFTALK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

TALK has a Current Ratio of 6.51. This indicates that TALK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.51, TALK belongs to the top of the industry, outperforming 95.05% of the companies in the same industry.
TALK has a Quick Ratio of 6.51. This indicates that TALK is financially healthy and has no problem in meeting its short term obligations.
TALK's Quick ratio of 6.51 is amongst the best of the industry. TALK outperforms 95.05% of its industry peers.
Industry RankSector Rank
Current Ratio 6.51
Quick Ratio 6.51
TALK Yearly Current Assets VS Current LiabilitesTALK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 140.00% over the past year.
The Revenue has grown by 17.43% in the past year. This is quite good.
The Revenue has been growing by 37.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)140%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
Revenue 1Y (TTM)17.43%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%17.92%

3.2 Future

Based on estimates for the next years, TALK will show a very strong growth in Earnings Per Share. The EPS will grow by 168.61% on average per year.
TALK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.05% yearly.
EPS Next Y308%
EPS Next 2Y237.5%
EPS Next 3Y168.61%
EPS Next 5YN/A
Revenue Next Year19.26%
Revenue Next 2Y20.45%
Revenue Next 3Y19.32%
Revenue Next 5Y21.05%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TALK Yearly Revenue VS EstimatesTALK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
TALK Yearly EPS VS EstimatesTALK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 134.00, the valuation of TALK can be described as expensive.
TALK's Price/Earnings is on the same level as the industry average.
TALK's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.57.
TALK is valuated rather expensively with a Price/Forward Earnings ratio of 23.53.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TALK is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of TALK to the average of the S&P500 Index (23.09), we can say TALK is valued inline with the index average.
Industry RankSector Rank
PE 134
Fwd PE 23.53
TALK Price Earnings VS Forward Price EarningsTALK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of TALK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 492.67
EV/EBITDA N/A
TALK Per share dataTALK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TALK's earnings are expected to grow with 168.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y237.5%
EPS Next 3Y168.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TALK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TALKSPACE INC

NASDAQ:TALK (10/23/2025, 4:55:31 PM)

After market: 2.69 +0.01 (+0.37%)

2.68

+0.05 (+1.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)10-30 2025-10-30/amc
Inst Owners59.77%
Inst Owner Change-0.03%
Ins Owners3.93%
Ins Owner Change-0.91%
Market Cap448.82M
Revenue(TTM)202.61M
Net Income(TTM)2.87M
Analysts81.54
Price Target4.9 (82.84%)
Short Float %3.41%
Short Ratio4.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.09%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-2.09%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)-0.33%
Revenue beat(8)3
Avg Revenue beat(8)0.39%
Revenue beat(12)6
Avg Revenue beat(12)0.99%
Revenue beat(16)7
Avg Revenue beat(16)-0.77%
PT rev (1m)0%
PT rev (3m)-4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.83%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.11%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-0.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.03%
Valuation
Industry RankSector Rank
PE 134
Fwd PE 23.53
P/S 2.22
P/FCF 492.67
P/OCF 51.61
P/B 3.97
P/tB 3.97
EV/EBITDA N/A
EPS(TTM)0.02
EY0.75%
EPS(NY)0.11
Fwd EY4.25%
FCF(TTM)0.01
FCFY0.2%
OCF(TTM)0.05
OCFY1.94%
SpS1.21
BVpS0.67
TBVpS0.67
PEG (NY)0.44
PEG (5Y)N/A
Graham Number0.55
Profitability
Industry RankSector Rank
ROA 2.16%
ROE 2.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.41%
GM 44.34%
FCFM 0.45%
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
F-Score7
Asset Turnover1.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 431.06%
Cap/Sales 3.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 31.8%
Current Ratio 6.51
Quick Ratio 6.51
Altman-Z 12.87
F-Score7
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)224%
Cap/Depr(5y)197.42%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)140%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
EPS Next Y308%
EPS Next 2Y237.5%
EPS Next 3Y168.61%
EPS Next 5YN/A
Revenue 1Y (TTM)17.43%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%17.92%
Revenue Next Year19.26%
Revenue Next 2Y20.45%
Revenue Next 3Y19.32%
Revenue Next 5Y21.05%
EBIT growth 1Y83.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year450.73%
EBIT Next 3Y135.19%
EBIT Next 5Y109.41%
FCF growth 1Y102.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y120.84%
OCF growth 3YN/A
OCF growth 5YN/A